Varma Mutual Pension Insurance Co purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 399,574 shares of the company’s stock, valued at approximately $51,345,000.
A number of other large investors have also recently added to or reduced their stakes in MKGAF. Emerald Investment Advisers LLC purchased a new position in Merck KGaA in the second quarter worth approximately $3,546,000. Westpac Banking Corp acquired a new stake in Merck KGaA during the second quarter worth $4,249,000. TRB Wealth Management LLC purchased a new stake in Merck KGaA in the second quarter valued at $955,000. Sumitomo Life Insurance Co. purchased a new stake in Merck KGaA in the second quarter valued at $2,951,000. Finally, Korea Investment CORP acquired a new position in shares of Merck KGaA in the 2nd quarter valued at $239,191,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Stock Performance
OTCMKTS MKGAF opened at $163.21 on Friday. The stock has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The stock has a fifty day simple moving average of $162.62 and a 200-day simple moving average of $148.46.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
